Kelly D. Deck
Equibles does not estimate personal net worth.
Get an email with a short summary when Inhibrx Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get INBX alertsAbout Kelly D. Deck
Kelly D. Deck is recorded as CFO at Inhibrx Biosciences, Inc. (INBX). The newest filing on record that lists Kelly D. Deck as CFO at Inhibrx Biosciences, Inc. (INBX) is dated April 23, 2026. The proxy statement of Inhibrx Biosciences, Inc. reports total compensation of $923,696 for Kelly D. Deck in fiscal 2025, including a base salary of $493,485. Disclosed compensation is on record for 3 fiscal years. Inhibrx Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inhibrx Biosciences, Inc. includes Mark P. Lappe (CEO and Board Member), Douglas G. Forsyth (Board Member), Jon Faiz Kayyem (Board Member) and 2 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 23, 2026
Company network
Leadership on record at Inhibrx Biosciences, Inc.
- Mark P. Lappe CEO, Board Member
- Douglas G. Forsyth Board Member
- Jon Faiz Kayyem Board Member
- Kimberly Manhard Board Member
- Kristiina Vuori Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Inhibrx Biosciences, Inc. (INBX) | C.P.A. Chief Financial Officer | $493,485 | $923,696 |
| 2024 | Inhibrx Biosciences, Inc. (INBX) | C.P.A. Chief Financial Officer | $460,100 | $4,267,254 |
| 2023 | Inhibrx Biosciences, Inc. (INBX) | C.P.A. Chief Financial Officer | $430,000 | $1,148,899 |
Recent activity
No call appearances or filed executive changes recorded yet.